Latest News
eXoZymes, Inc.
- eXoZymes CEO to Discuss Commercialization, Key Milestones, and Potential Catalysts in Fireside Chat with Water Tower Research
- eXoZymes CEO to Discuss Commercialization, Key Milestones, and Potential Catalysts in Fireside Chat with Water Tower Research
- eXoZymes CEO to Discuss Commercialization, Key Milestones, and Potential Catalysts in Fireside Chat with Water Tower Research
- EXoZymes CEO to Discuss Commercialization, Key Milestones, and Potential Catalysts in Fireside Chat With Water Tower Research
- Form 4 eXoZymes Inc: Tyler Paz Korman (Chief Scientific Officer) For: 19 August
- Form 4 eXoZymes Inc: Lon E. Bell (Director) For: 1 October By Investing.com
- Form 4 eXoZymes Inc: Christopher A. Marlett (Director, 10% Owner) For: 1 October
- Exozymes Inc. Director James Joseph Lalonde Granted 10,000 Stock Options
- A director receives 25,000 Exozymes (EXOZ) stock options with a $6.28 exercise price.
- A director receives a 10,000-share option from ExoZymes (EXOZ), with a $6.28 exercise price.
- Director Bell receives 10,000 options at $6.28 a share from EXOZYMES (EXOZ).
- eXoZymes Inc. Stock Price Prediction: Today, Tomorrow, Next Week (EXOZ)
Headlines from the last 30 days, linking to the original publishers. See all market news →